Who owns MEI PHARMA INC?
- Ticker: LITS
- CUSIP Number: 55279b301
Tip: Access positions for across all investors
Analyze quarterly positions in Mei Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mei Pharma stock
Who bought or sold MEI PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Renaissance Technologies | 1.5M | $2.0M | 51% | Dec 2025 |
|
| Vanguard Group | 1.1M | $1.5M | 54% | Dec 2025 |
|
| Vanguard Capital Management | 1.0M | $1.2M | 100% | Mar 2026 |
|
| Citadel Advisors | 768k | $890k | -46% | Mar 2026 |
|
| Marshall Wace | 759k | $1.0M | 955% | Dec 2025 |
|
| Two Sigma Investments | 614k | $713k | -7% | Mar 2026 |
|
| Geode Capital Management | 401k | $466k | 21% | Mar 2026 |
|
| Quarry | 200k | $264k | -33% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 194k | $225k | 100% | Mar 2026 |
|
| BlackRock | 158k | $183k | 0% | Mar 2026 |
|
| State Street Corporation | 115k | $152k | 0% | Dec 2025 |
|
| XTX Topco | 111k | $147k | 62% | Dec 2025 |
|
| Susquehanna International | 94k | $125k | -62% | Dec 2025 |
|
| Quadrature Capital | 85k | $112k | 100% | Dec 2025 |
|
| Northern Trust | 80k | $106k | 19% | Dec 2025 |
|
| Jane Street | 80k | $93k | -47% | Mar 2026 |
|
| Morgan Stanley | 71k | $83k | 0% | Mar 2026 |
|
| ADAR1 Capital Management | 67k | $78k | 0% | Mar 2026 |
|
| UBS Group | 51k | $60k | -59% | Mar 2026 |
|
| Nomura Asset Management International | 30k | $35k | 100% | Mar 2026 |
|
| Virtu Financial | 27k | $35k | 98% | Dec 2025 |
|
| Group One Trading | 23k | $27k | -13% | Mar 2026 |
|
| Vanguard Global Advisers | 18k | $21k | 100% | Mar 2026 |
|
| Engineers Gate Manager | 14k | $18k | 100% | Dec 2025 |
|
| Tower Research Capital | 3.2k | $4.3k | -86% | Dec 2025 |
|
| Bank Julius Baer & Co. Ltd, Zurich | 2.2k | $2.5k | 100% | Mar 2026 |
|
| Newbridge Financial Services Group | 2.0k | $2.3k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 462.00 | $536.012400 | 0% | Mar 2026 |
|
| HighMark Wealth Management | 287.00 | $332.001600 | 0% | Mar 2026 |
|
| Evermay Wealth Management | 126.00 | $147.004200 | 0% | Mar 2026 |
|
| MAI Wealth Advisors | 75.00 | $87.000000 | 0% | Mar 2026 |
|
| Wells Fargo & Company | 25.00 | $29.000000 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 4.00 | $5.000000 | 100% | Mar 2026 |
|
| Farther Finance Advisors | 2.00 | $2.000000 | 100% | Mar 2026 |
|
| Advisor Group Holdings | 2.00 | $2.000000 | 0% | Dec 2025 |
|
| SBI Securities | 1.00 | $1.000000 | 0% | Mar 2026 |
|
| International Assets Investment Management | 1.00 | $1.000000 | 0% | Mar 2026 |
|
| Citigroup | 1.00 | $1.000000 | 100% | Mar 2026 |
|
| CWM | 1.00 | $0 | 0% | Dec 2025 |
|
Who sold out of Mei Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Mozayyx Management | Dec 2025 | 560k | $739k |
| Vgi Partners Pty | Sep 2025 | 349k | $845k |
| Polar Securities | Dec 2025 | 277k | $365k |
| Two Sigma Advisers | Dec 2025 | 204k | $270k |
| Alpine Partners VI | Dec 2025 | 50k | $66k |
| Hrt Financial | Dec 2025 | 32k | $42k |
| Macquarie Group | Sep 2025 | 30k | $73k |
| Bridgeway Capital Management | Sep 2025 | 27k | $65k |
| Squarepoint Ops | Dec 2025 | 15k | $19k |
| Two Sigma Securities | Dec 2025 | 12k | $16k |
| Simplex Trading | Sep 2025 | 8.2k | $19k |
| Jpmorgan Chase & Co | Sep 2025 | 67.00 | $161.778200 |